Li et al[34] used bioinformatics to predict CDK1 as a potential target of HBV-associated HCC, and then searched for the treatment of HBV-associated HCC by reverse network pharmacological analysis of the major herbal small molecules, quercetin being one of them. The gene discussed is CDK1; the disease is hepatocellular carcinoma.